| __timestamp | Blueprint Medicines Corporation | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 1513000 |
| Thursday, January 1, 2015 | 48588000 | 12573000 |
| Friday, January 1, 2016 | 81131000 | 42238000 |
| Sunday, January 1, 2017 | 144687000 | 69800000 |
| Monday, January 1, 2018 | 243621000 | 113773000 |
| Tuesday, January 1, 2019 | 331450000 | 179362000 |
| Wednesday, January 1, 2020 | 326860000 | 266946000 |
| Friday, January 1, 2021 | 601033000 | 438633000 |
| Saturday, January 1, 2022 | 477419000 | 461645000 |
| Sunday, January 1, 2023 | 427720000 | 387332000 |
| Monday, January 1, 2024 | 341433000 | 320653000 |
Unlocking the unknown
In the rapidly evolving biotech sector, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Blueprint Medicines Corporation and CRISPR Therapeutics AG have demonstrated significant investment in R&D, reflecting their dedication to advancing medical breakthroughs.
From 2014 to 2023, Blueprint Medicines increased its R&D budget by over 1,200%, peaking in 2021 with a 600% rise compared to 2014. Meanwhile, CRISPR Therapeutics AG saw a staggering 25,000% increase in the same period, highlighting its aggressive push in gene-editing technologies.
Despite a slight dip in 2023, both companies maintain robust R&D investments, underscoring their roles as leaders in biotech innovation. This trend not only showcases their growth but also their potential to revolutionize healthcare solutions in the coming years.
Analyzing R&D Budgets: Insmed Incorporated vs CRISPR Therapeutics AG
Blueprint Medicines Corporation or Lantheus Holdings, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and Alkermes plc
Blueprint Medicines Corporation vs Opthea Limited: Strategic Focus on R&D Spending
R&D Spending Showdown: Blueprint Medicines Corporation vs Ultragenyx Pharmaceutical Inc.
Blueprint Medicines Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Celldex Therapeutics, Inc.
Comparing Innovation Spending: CRISPR Therapeutics AG and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs Mesoblast Limited
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.